International Journal of Contemporary Pediatrics

Bhoraniya B et al. Int J Contemp Pediatr. 2026 Oct;13(10):2151-2153

https://www.ijpediatrics.com

pISSN 2349-3283 | eISSN 2349-3291

All rashes in the neonatal period are not benign: a rare case of congenital cutaneous candidiasis in a neonate with cholestasis

Bhavin Bhoraniya1, Asmi Vora2, Purbasha Mishra3*, Unnati Asari3, Hetal Vora3, Jeta Buch4


1Shardaben Hospital, NHL Medical College, Ahmedabad, Gujarat, India

2B. J. Medical College, Ahmedabad, Gujarat, India

3Department of Pediatrics, Shardaben Hospital, NHL Medical College, Ahmedabad, Gujarat, India

4Department of Dermatology, Shardaben hospital, NHL medical college, Ahmedabad, Gujarat, India

Received: 28 July 2026

Accepted: 07 September 2026

*Correspondence:

Dr. Purbasha Mishra,

E-mail: purbimishra25@gmail.com

Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

ABSTRACT

Neonatal rashes manifest in various forms-papular, pustular, vesicular, or bullous lesions-and both their morphology and the day of onset provide key diagnostic clues. Benign causes include erythema toxicum neonatorum, transient pustular melanosis, miliaria. It is important to distinguish them from pathological causes like bullous impetigo, neonatal herpes, neonatal varicella or genetic conditions. In this report, we describe a case of congenital candidiasis, presenting with generalized rash with varied morphology and had systemic involvement in form of cholestasis. A systematic approach with proper history, general examination and investigations leads to early diagnosis and reduces morbidity in these babies.

Keywords: Newborn, Congenital candidiasis, Neonatal rash, Cholestasis

INTRODUCTION

Neonates present with varied morphology of rash-maculopapular to vesicular and bullous picture. The diagnosis depends on the morphology, distribution, age of onset of lesions and presence of systemic features.1 Congenital cutaneous candidiasis (CCC) is a rare intrauterine fungal infection seen in neonates in the first week of life. It presents with manifestations ranging from localized skin disease to systemic involvement in the form of respiratory distress, sepsis, and death.2

The prevalence of candidal vaginitis during pregnancy ranges from 10% to 35%, whereas candidal chorioamnionitis is an uncommon complication, affecting fewer than 1% of affected women, with potential fetal involvement.3 While often self-limiting, untreated infection can cause serious systemic disease in preterm and extremely low birth weight (LBW) infants.

CASE REPORT

We describe a case of a full-term male neonate with gestational age 38 weeks, birth weight 2.3 kg, small for gestational age (SGA), born to a primigravida mother, with no significant perinatal history. There was no history of vaginal discharge or preterm rupture of membranes. The baby presented on day 7 of life with yellowish discoloration of body extending up to the legs. Parents also complained of rash over the trunk and extremities, onset since day 5 of life. On examination, baby had erythematous maculopapular and pustular rash over trunk, extremities, axilla, groin with areas of desquamation (Figure 1). Icterus was present, extending to the palms and soles. Systemic examination was normal. Possibility of erythema toxicum neonatorum, staphylococcal infection, herpes or candida infection was considered.4,5 Investigations showed leukocytosis with conjugated hyperbilirubinemia with transaminitis (as shown in Table 1). Urine microscopy was normal and culture was sterile. Chest X-ray, ultrasound cranium and abdomen were unremarkable.

In view of generalized rash with multiple papular and pustular lesions with desquamation, cutaneous candidiasis was considered. KOH smear showed multiple budding spores and pseudo hyphae confirmative of cutaneous candidiasis. Baby had extensive rash with systemic involvement in form of transaminitis, so systemic antifungal therapy was considered. The baby was managed with intravenous fluconazole at dose of 12 mg/kg/day and topical therapy with 1% clotrimazole, with gradual resolution of skin lesions by end of one week. Fluconazole was continued for 2 weeks. Blood culture was sterile. On follow up at 4 weeks there was complete resolution of skin lesions and weight gain was adequate.

Table 1: Investigations in index case.
Table reproduced from source PDF page 2

*Varies with postnatal age and gestation of babies

Figure 1 (A-C): Neonate with maculopapular rash, pustules, skin peeling seen in groin (A), trunk, back and extremities (B), resolution of skin lesions by the end of one week (C).
Figure 1 (A-C): Neonate with maculopapular rash, pustules, skin peeling seen in groin (A), trunk, back and extremities (B), resolution of skin lesions by the end of one week (C).

DISCUSSION

CCC is a rare invasive fungal infection, seen in preterm and LBW neonates within the first week of life.6,7 A diffuse rash with varied morphology is seen, appearing as generalized peeling, desquamation, burn-like dermatitis, maculopapular rash or rarely pustules or vesicles.5 Risk factors include preterm babies, vaginal candidiasis in mother, presence of intrauterine device (IUD) or invasive procedures during pregnancy. Presence of burn-like dermatitis, signs of sepsis or isolation of candida species in blood, urine or cerebrospinal fluid warrant systemic therapy.8 Early treatment with systemic therapy for two weeks prevents systemic dissemination, leads to early recovery and reduces mortality in preterm and LBW babies.9 The clinical course is usually benign and there is excellent response to antifungal therapy.

CONCLUSION

Physicians must consider non-benign causes of neonatal rashes in sick cases with atypical presentation. Cutaneous candidiasis is a benign self-limiting infection, which if treated early can prevent systemic dissemination.

Funding: No funding sources

Conflict of interest: None declared

Ethical approval: Not required

REFERENCES

  1. 1. Kliegman RM. Nelson Textbook of Pediatrics. 21st ed. Philadelphia: Elsevier. 20191641.
  2. 2. Khambadkone SM, Dixit KM, Divekar A, Joshi SM, Irani SF, Desai M. Congenital Candidiasis. Indian Pediatr. 1996;33(1):512-6.
  3. 3. Darmstadt GL, Dinulos JG, Miller Z: Congenital cutaneous candidiasis: Clinical presentation, pathogenesis, and management guidelines. Pediatrics. 2000;105(2):438-44.
  4. 4. Afra TP, Daroach M, Mahajan R, De D, Handa S. Pustular lesions in the neonate: Focused diagnostic approach based on clinical clues. Indian J Dermatol Venereol Leprol. 2022;88(6):708-16.
  5. 5. Reynolds S, Punia H, Harrison LB, Rodriguez-Garcia C. A guide to neonatal rashes. Paediatrics and Child Health. 2022;1:463-70.
  6. 6. Ruiz-Cabrera JR, Meléndrez-Vásquez D, Moreno DM, Prieto-Jure R. Congenital cutaneous candidiasis in a premature neonate: A case report. Clin Case Rep. 2025;10(5):e05773.
  7. 7. Shope C, Ritter A, Karlin S, Lee LW, Cotton CH. Congenital Cutaneous Candidiasis in Preterm Infants. Neoreviews. 20231;24(3):175-80.
  8. 8. Chen KL, Chien MM, Chen CY, Chiu HC. Congenital cutaneous candidiasis. Case Reports. 2016;11:2016216037.
  9. 9. Kaufman DA, Coggins SA, Zanelli SA, Weitkamp JH. Congenital Cutaneous Candidiasis: Prompt Systemic Treatment Is Associated with Improved Outcomes in Neonates. Clin Infect Dis. 2017;15(10):1387-95.